Theratechnologies to Present at the H.C. Wainwright Global Life Sciences Conference
MONTREAL, Feb. 25, 2021 – Theratechnologies (NASDAQ: THTX) announced that its CEO, Paul Levesque, will present at the H.C. Wainwright Global Life Sciences Conference on March 9-10, 2021. The presentation will be available on demand from March 9 at 7:00 a.m. ET via the Company’s website and the virtual conference link. It will remain archived for 90 days. Theratechnologies focuses on innovative therapies that address unmet medical needs, reinforcing its commitment to advancing biopharmaceutical solutions.
- None.
- None.
MONTREAL, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Paul Levesque, President and Chief Executive Officer, will present at the H.C. Wainwright Global Life Sciences Conference being held virtually March 9 – 10, 2021.
The presentation will be available on demand beginning Tuesday, March 9, 2021 at 7:00 a.m. ET on the ‘News’ section of the Company’s website or via the virtual conference link, and will be archived for 90 days.
About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.
For media inquiries:
Denis Boucher
Vice-President, Communications and Corporate Affairs
514-336-7800
For investor inquiries:
Leah Gibson
Senior Director, Investor Relations
lgibson@theratech.com
617-356-1009
FAQ
When is Theratechnologies presenting at the H.C. Wainwright Global Life Sciences Conference?
What time will the Theratechnologies presentation be available on demand?
How long will the Theratechnologies presentation be archived?
What is the stock symbol for Theratechnologies?